Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01980771
What this trial is testing

Barbershop Talk: HIV Prevention for African American Heterosexual Men

Who this might be right for
HIV
State University of New York - Downstate Medical Center 860
Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT01646762
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Mayo Clinic 13
Testing effectiveness (Phase 2)Study completedNCT04914286
What this trial is testing

GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Genfleet Therapeutics (Shanghai) Inc. 148
Early research (Phase 1)Looking for participantsNCT05857969
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more
Florida International University 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649369
What this trial is testing

A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusions (Mpe)
Shanghai Jeyou Pharmaceutical Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT00370890
What this trial is testing

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Who this might be right for
Nasopharyngeal Cancer
Chinese University of Hong Kong 104
Large-scale testing (Phase 3)Looking for participantsNCT06588413
What this trial is testing

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplantation
Augusta University 172
Not applicableNot Yet RecruitingNCT06625788
What this trial is testing

Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)

Who this might be right for
Colorectal Cancer Control and Prevention
Asociación Española de Gastroenterología 200
Not applicableEnded earlyNCT00001803
What this trial is testing

Von Hippel-Lindau Disease Genetic Epidemiology Study

Who this might be right for
Von Hippel Lindau DiseaseKidney Neoplasms
National Cancer Institute (NCI) 546
Large-scale testing (Phase 3)Active Not RecruitingNCT04181827
What this trial is testing

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 419
Testing effectiveness (Phase 2)Study completedNCT01001442
What this trial is testing

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Biotest Pharmaceuticals Corporation 35
Not applicableUnknownNCT03651986
What this trial is testing

Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules

Who this might be right for
Pulmonary Nodules
AnchorDx Medical Co., Ltd. 10,560
Not applicableWithdrawnNCT03115528
What this trial is testing

Difference in the Estimation of Prognosis

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03794167
What this trial is testing

BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Soonchunhyang University Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT06503107
What this trial is testing

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)UnknownNCT03457844
What this trial is testing

Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor G3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07107529
What this trial is testing

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Who this might be right for
Multiple Myeloma (MM)
European Myeloma Network B.V. 150
Large-scale testing (Phase 3)Study completedNCT01360853
What this trial is testing

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Traws Pharma, Inc. 160
Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Next Page